医学
多塔
成纤维细胞活化蛋白
肺
孤立性纤维性肿瘤
放射科
PET-CT
核医学
正电子发射断层摄影术
癌症
内科学
体内
生物技术
生物
遗传学
干细胞
川地34
作者
Annan Zhang,Huiyuan Zhang,Xin Zhou,Zhongwu Li,Nan Li
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2021-04-07
卷期号:46 (11): e534-e537
被引量:13
标识
DOI:10.1097/rlu.0000000000003598
摘要
A 52-year-old man complained of pain in the right lower chest wall for a month. Chest CT found a subpleural mass, but failed to identify the nature of the tumor. The 18F-FDG PET/CT was conducted for further diagnosis and staging, which showed the mass in the lower lobe of the right lung with mild radioactive uptake of 18F-FDG. The patient was subsequently enrolled in an ongoing clinical trial using 68Ga-DOTA-FAPI-04 (fibroblast activation protein inhibitor) PET/CT. The mass showed intensive 68Ga-DOTA-FAPI-04 uptake, which was subsequently confirmed as solitary fibrous tumors of the pleura by pathology. Our case demonstrated that the 68Ga-DOTA-FAPI-04 might have excellent tumor affinity of solitary fibrous tumors of the pleura.
科研通智能强力驱动
Strongly Powered by AbleSci AI